NIH Funding Opportunities (Notices, PA, RFA)

Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 1 hour 35 min ago
Notice of Special Interest (NOSI): Administrative Supplements to Support Extramural Collaborators for Notified Applicants for the Bench-to-Bedside and Back Program (BtB) (Clinical Trial Optional)
Notice NOT-OD-22-185 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Integrated Physiology of Exocrine and Endocrine Pancreas in Type 1 Diabetes (R01 - Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-22-022 from the NIH Guide for Grants and Contracts. This Funding Opportunity will support multi-disciplinary teams to examine interactions between exocrine and endocrine pancreas to support the study of T1D. The purpose of this opportunity is to encourage integrated study of the whole pancreas to enable characterization of direct and indirect crosstalk between exocrine and endocrine compartments, and identification of the mechanisms by which that crosstalk occurs and can be disrupted in T1D and other forms of diabetes. Development of assays or platforms to allow for broader investigation into these questions could also be supported.
Categories: Job Watch, Literature Watch
Coordinating Center for the NICHD Population Dynamics Centers Research Infrastructure Program FY 2023 (R24 Clinical Trial Not Allowed)
Funding Opportunity RFA-HD-23-027 from the NIH Guide for Grants and Contracts. The purpose of this funding announcement is to support a coordinating center for the NICHD Population Dynamics Centers Research Infrastructure Programs.
Categories: Job Watch, Literature Watch
Notice for the NIGMS Grant Writing Webinar Series for Institutions Building Research and Research Training Capacity
Notice NOT-GM-22-041 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Correction to Announcement Type for "PAR-22-142: NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required)"
Notice NOT-NS-22-120 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Practice-Based Research Integrating Multidisciplinary Experiences in Dental Schools (PRIMED) (U01 Clinical Trial Not Allowed)
Notice NOT-DE-22-013 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of NIDCR Participation in RFA-CA-22-040, The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed)
Notice NOT-DE-22-014 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Pre-Application Webinar for Cancer Prevention and Control Clinical Trials Planning Grant Program (PAR-22-173 (R34) and PAR-22-174 (U34))
Notice NOT-CA-22-115 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for ClinGen Genomic Curation Expert Panels (U24 Clinical Trial Not Allowed)
Notice NOT-HD-22-036 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notification to the community of change in maximum salary provided by NINDS K award mechanisms for clinician-scientists.
Notice NOT-NS-23-005 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Extension of PAR-20-300, "Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)"
Notice NOT-HD-22-031 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Extension of PAR-20-299, "Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)"
Notice NOT-HD-22-030 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Interventions that Address Structural Racism to Reduce Kidney Health Disparities - (U01 - Clinical Trial Required)
Funding Opportunity RFA-DK-22-014 from the NIH Guide for Grants and Contracts. The Interventions that Address Structural Racism to Reduce Kidney Health Disparities Consortium aims to foster community-engaged intervention research to address structural racism to reduce health disparities among individuals living with kidney disease. This Funding Opportunity Announcement (FOA) invites applications for Intervention Sites that will work collaboratively with a Research Coordinating Center (RCC) (link to companion RFA) to develop and test meaningful interventions that aim to dismantle or mitigate the effects of structural racism to reduce kidney health disparities. Studies proposed by the successful applicants may be substantially revised prior to being undertaken by the Consortium, including the potential of harmonizing intervention components and data collection measures across Intervention Sites.
Categories: Job Watch, Literature Watch
Interventions that Address Structural Racism to Reduce Kidney Health Disparities Research Coordinating Center (U24 - Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-22-015 from the NIH Guide for Grants and Contracts. The Interventions that Address Structural Racism to Reduce Kidney Health Disparities Consortium aims to foster community-engaged intervention research to address structural racism to reduce health disparities among individuals living with kidney disease. The Consortium will consist of one Research Coordinating Center and multiple Intervention Sites (link to companion RFA) that will work collaboratively to develop, implement and evaluate meaningful interventions that aim to dismantle or mitigate the effects of structural racism to reduce kidney health disparities. This Funding Opportunity Announcement (FOA) invites applications for the Research Coordinating Center (RCC) that will lead, manage, and harmonize efforts for the Consortium. The specific activities of the RCC will include: 1) providing organization, management, and administrative support of Consortium activities; 2) providing research coordination, data management and data analyses for Consortium studies; and 3) fostering research collaborations and helping to build a community of investigators with skills to develop, implement, and disseminate effective, scalable, and sustainable interventions that address the structural drivers of kidney health disparities.
Categories: Job Watch, Literature Watch
Geroscience Course (R25 Independent Clinical Trial Not Allowed)
Funding Opportunity PAR-22-214 from the NIH Guide for Grants and Contracts. The overarching goal of this PAR is to support educational activities that complement and/or enhance the training of the clinical and research workforce, and bring awareness of Geroscience to members of the public, by supporting creative educational activities with a primary focus on the development and integration of basic, applied, translational, and clinical topics in Geroscience including: Curriculum or Methods Development, Courses for Skills Development, Research Experiences and Networking, Development of a Repository of Important Reviews and Opinion Pieces and Clinical Trials in Progress, Outreach and Creation of Lay Public Documents on Geroscience.
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Promoting Mechanistic Research on Therapeutic and Other Biological Properties of Minor Cannabinoids and Terpenes
Notice NOT-AT-22-027 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change to Applications and Submission Information for RFA-AR-23-001, "Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional)"
Notice NOT-AR-23-003 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
HEAL Initiative: Research Studies to Develop and Implement Interventions to Prevent Opioid Misuse in Community Health Centers (R61/R33 Clinical Trial Required)
Funding Opportunity RFA-DA-23-048 from the NIH Guide for Grants and Contracts. NIH is issuing this Funding Opportunity Announcement (FOA) in response to the declared public health emergency issued by the Secretary, HHS, for the national opioid crisis. This research is part of the Helping to End Addiction Long-term (HEAL) Prevention Initiative, a portfolio of research focused on the prevention of opioid misuse and opioid use disorder funded under NIHs HEAL Initiative. The National Institute on Drug Abuse (NIDA) seeks to address the urgency and magnitude of the opioid crisis by developing and testing new or adapted interventions to prevent opioid misuse among patients served by community health centers (CHCs), and/or developing and testing implementation strategies for screening and referral to preventive interventions for misuse of opioids and other substances among patients served by CHCs. Research will be supported through exploratory/developmental phase awards (R61/R33) that may not exceed 5 years, allocating up to two years of funding for development of the project and up to four years for a full test of the research aims.
Categories: Job Watch, Literature Watch
Biology of Bladder Cancer (R01 Clinical Trial Optional)
Funding Opportunity PAR-22-218 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications investigating the biology and underlying mechanisms of bladder cancer. Bladder cancer is a significant health problem both in the United States and globally. Because of the high incidence and frequent tumor recurrence, bladder cancer exacts an outsized medical burden. While recent progress has been made in the molecular profiling of bladder cancers and identification of mutated genes, relatively little is known regarding the molecular mechanisms driving initiation, progression, and malignancy of bladder cancer. Furthermore, our understanding of biological processes of the normal bladder at the molecular, cell and organ levels is limited. Fundamental knowledge of how molecular and cellular functions of the bladder are altered in cancer will aid our understanding of bladder cancer biology and interventions. Applications that involve multidisciplinary teams and use clinical specimens or investigate both normal and cancer processes are encouraged.
Categories: Job Watch, Literature Watch
Biology of Bladder Cancer (R21 Clinical Trial Optional)
Funding Opportunity PAR-22-219 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications investigating the biology and underlying mechanisms of bladder cancer. Bladder cancer is a significant health problem both in the United States and globally. Because of the high incidence and frequent tumor recurrence, bladder cancer exacts an outsized medical burden. While recent progress has been made in the molecular profiling of bladder cancers and identification of mutated genes, relatively little is known regarding the molecular mechanisms driving initiation, progression, and malignancy of bladder cancer. Furthermore, our understanding of biological processes of the normal bladder at the molecular, cell and organ levels is limited. Fundamental knowledge of how molecular and cellular functions of the bladder are altered in cancer will aid our understanding of bladder cancer biology and interventions. Applications that involve multidisciplinary teams and use clinical specimens or investigate both normal and cancer processes are encouraged.
Categories: Job Watch, Literature Watch